Standout Papers

Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger... 2016 2026 2019 2022 482
  1. Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits (2016)
    Antonius Baartscheer, Cees A. Schumacher et al. Diabetologia
  2. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation (2017)
    Laween Uthman, Antonius Baartscheer et al. Diabetologia

Immediate Impact

3 by Nobel laureates 8 from Science/Nature 55 standout
Sub-graph 1 of 20

Citing Papers

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Spatially organized cellular communities form the developing human heart
2024 StandoutNature
2 intermediate papers

Works of Jan W.T. Fiolet being referenced

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
2018
Presence of Functional Sarcoplasmic Reticulum in the Developing Heart and Its Confinement to Chamber Myocardium
2000

Author Peers

Author Last Decade Papers Cites
Jan W.T. Fiolet 798 765 570 918 17 1.7k
Hideki Doi 682 545 575 475 47 2.0k
Keisuke Ohba 371 921 340 374 24 1.6k
Sajoscha Sorrentino 458 361 342 250 17 1.3k
Anneke Koeman 412 292 344 452 18 1.2k
Michael C. Tobes 224 494 514 299 29 1.6k
Sankaridrug M. Periyasamy 968 325 207 336 41 1.6k
D.M. Wieland 308 1014 395 136 41 2.2k
Elena Kaschina 600 1115 225 575 43 1.8k
Anke Dahlmann 393 346 160 288 32 2.0k
Eckhard P. Kromer 357 1127 157 142 45 1.7k

All Works

Loading papers...

Rankless by CCL
2026